Skip to main content
. 2021 Feb 23;2021:6654168. doi: 10.1155/2021/6654168

Figure 2.

Figure 2

Overview of the medical treatment options for diabetic macular edema (adapted from Urias et al. [15]). NSAIDS: nonsteroidal anti-inflammatory drug; VEGF: vascular endothelial growth factor; DARPin: designed ankyrin repeat protein; FGF: fibroblast growth factor beta; PDGF: platelet-derived growth factor; CCR: chemokine receptor; IGF-1: insulin-like growth factor-1; EPO: erythropoietin.